ISSN 2149-2263 | E-ISSN 2149-2271 Home      
 
Volume : 22 Issue : 6
Current Issue Archive Popular Article Ahead of Print

   
Quick Search





 
The Anatolian Journal of Cardiology Renal and metabolic effects of valsartan [Anatol J Cardiol]
Anatol J Cardiol. 2014; 14(Suppl 2): 14-19 | DOI: 10.5152/akd.2014.00003  

Renal and metabolic effects of valsartan

Tevfik Ecder1
Department of Internal Medicine, Division of Nephrology, Faculty of Medicine, İstanbul Bilim University; İstanbul-Turkey

It is known that the drugs which suppress the renin-angiotensin-aldosterone system can prevent target organ damage, independent of their blood pressure lowering effects. Besides, it has been reported that this group of drugs has positive metabolic effects. There are many studies showing that valsartan, being an angiotensin receptor blocker and widely used in hypertension treatment, has cardioprotective and renoprotective effects in high risk patients. It has been seen in these studies that, valsartan treatment has a decreasing effect on proteinuria, independent of its blood pressure lowering effects in the patients having either diabetic and non-diabetic nephropathy. In this review, the studies investigating the renal effects of valsartan will be mentioned. Additionally, the studies about the metabolic effects of valsartan will be reported.

Keywords: angiotensin receptor blocker, chronic kidney disease, metabolic, renal, valsartan


Tevfik Ecder. Renal and metabolic effects of valsartan. Anatol J Cardiol. 2014; 14(Suppl 2): 14-19


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share


Similar articles
PubMed
Google Scholar




 
 
KARE Publishing | Copyright © 2018 Turkish Society of Cardiology